CU Museum exhibit features botanical illustrations of cannabis
Who: Open to the public
​W³ó²¹³Ù:Cannabis: A Visual Perspective
When: Sept. 8 through Jan. 31
Where: CU Museum of Natural History, BioLounge Gallery
Admission: Free
The is presenting the exhibit, which features a juried selection of botanical illustrations rendered in watercolor, acrylic, oil, colored pencil, pastel, print and mixed media. The artwork is designed to educate the public about the scientific uses of botanical illustrations and highlight their aesthetic qualities. Visitors will get a unique perspective of how artists interpret plant life and incorporate their creative vision into their artwork.
The exhibit also provides the museum with opportunities to educate visitors about Colorado’s marijuana laws, university policies prohibiting the use, possession and distribution of marijuana and other drugs on campus, and to remind the community that ²ÊÃñ±¦µä remains a smoke-free campus.
Later this fall, the museum will host two science-focused lectures that examine cannabis research occurring on the ²ÊÃñ±¦µä campus. Lectures are free and open to the public. Seating is limited.
For more information, please visit the .
Diversity in Cannabis Sativa
Tues., Oct. 17, at 7 p.m.
Daniela Vergara, a ²ÊÃñ±¦µä postdoctoral researcher, will share the results of her studies on the genetic diversity of multiple cannabis varieties, including the variation we see in the whole genome, in the chemicals produced by the cannabis plant, and in the genes related to cannabinoid production.
Cannabis, Cannabinoids, and Health After Legalization
Wed., Nov. 29, at 7 p.m.
Given the increasing prevalence of recreational and medicinal marijuana and changing legal policies, understanding the effects of different forms of cannabis on the human body is an increasingly important topic. Cinnamon Bidwell, an assistant research professor in the CU Change Lab, will provide an overview of the current state of human cannabis research and limitations on conducting cannabis research due to federal regulations. She will propose a path forward for collecting data on the abuse liability and potential therapeutic effects of legal market cannabis products.